Anaphylaxis News and Research

RSS

Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.

New precision medicine trial shows promise for treating rare brain tumors

Papillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients.

13 Jul 2023

What are the effects of insect consumption on human health?

A systematic review of human studies reveals that insect proteins are as good as other protein sources in providing essential amino acids and other health benefits.

13 Jul 2023

Rising incidence of kiwifruit allergy in children: study highlights severe allergic reactions

Study aimed to compile Kiwifruit allergy recognition patterns to enhance patient management and clinical practice.

6 Jul 2023

From delicacy to danger: The rising tide of shellfish allergies in children revealed

Shellfish consumption is on the rise, but so are shellfish allergies, particularly among children. A recent review delves into the epidemiology, symptoms, diagnosis, and management of shellfish allergies, highlighting the need for improved diagnostic tools and potential allergen immunotherapy.

13 Jun 2023

Safety surveillance suggests that COVID-19 mRNA vaccination is safe for young children

Researchers presented the results of their rapid cycle analysis safety surveillance, which is a weekly surveillance monitoring of monovalent mRNA COVID-19 vaccines among all children below five years enrolled in the Vaccine Safety Datalink (VSD).

8 Jun 2023

Hay fever could be triggering other allergies, doctor reveals

Hay fever may be triggering an allergic reaction to foods such as fruits, vegetables, nuts and legumes, a doctor from a digital healthcare provider has revealed.

8 May 2023

Study assesses trends in buprenorphine initiation and retention in the United States

Treating opioid addiction should be much easier now than it was a few years ago, thanks to pandemic-era rule changes that aim to improve access to buprenorphine, a medicine proven to help in recovery.

25 Apr 2023

Diagnosis and treatment of food allergies using a molecular approach

Researchers discuss molecular methods for food allergy assessments, including diagnostic and prognostic markers, as well as existing therapies.

15 Mar 2023

A call to action proposed for health providers to ensure widest distribution, easy availability of naloxone

In 2021, 100,306 Americans died from drug overdoses – a 28.5 percent increase from the prior year – with 75,673 attributed to opioids.

16 Feb 2023

Researchers find a way to block anaphylaxis caused by peanut allergies

Researchers from Indiana University School of Medicine have found a way to block anaphylaxis caused by peanut allergies.

9 Feb 2023

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

A researchers emphasized the need to reconsider mRNA COVID-19 vaccination strategies in the future,

9 Feb 2023

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis.

25 Jan 2023

High burden of multi-food allergies among children and adults in the U.S.

A new study in the journal Annals of Allergy, Asthma & Immunology aimed to characterize the characteristics, prevalence, determinants, distribution, and psychosocial burden of multi-FA among adults and children in the US.

3 Jan 2023

New technologies and recent advances in the study of T cells and T-cell epitope discovery in food allergy research

In a recent study, scientists reviewed the latest technological advancements and T cell epitope discovery associated with food allergy.

28 Nov 2022

Study sheds new light on the role of IgA in food allergies

Food-specific immunoglobulin A present in the human gut does not provide protection against food allergies.

27 Nov 2022

Study: Only half of food allergic adult patients have immediate access to epinephrine

Epinephrine is the only medication that can stop anaphylaxis and it is critical that everyone with a food allergy has access to epinephrine to treat life threatening reactions.

10 Nov 2022

Treatment using CRISPR genome editing alleviates swelling attacks in hereditary angioedema patients

Hereditary angioedema (HAE) is a rare, genetic disorder characterized by severe, recurring, and unpredictable swelling attacks in various organs and tissues of the body, which can be painful, debilitating, and life-threatening.

10 Nov 2022

Anaphylaxis symptoms in most infants appear to resolve with a single dose of epinephrine

Although many parents of infants worry about their child having a food allergy, there has not been a lot of research into the presentation of anaphylaxis in infants.

10 Nov 2022

CDC Director signs decision memo allowing Novavax monovalent COVID-19 boosters for adults

Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.

24 Oct 2022

Comparative immunogenicity of COVID-19 vaccines in North California

In new research, researchers evaluated vaccine responses among North Californian residents, including differences in vaccine side effects and antibody (Ab) titers by age, sex, and vaccine type.

4 Oct 2022

Anaphylaxis News and Research

Further Reading

New precision medicine trial shows promise for treating rare brain tumors

What are the effects of insect consumption on human health?

Rising incidence of kiwifruit allergy in children: study highlights severe allergic reactions

From delicacy to danger: The rising tide of shellfish allergies in children revealed

Safety surveillance suggests that COVID-19 mRNA vaccination is safe for young children

Hay fever could be triggering other allergies, doctor reveals

Study assesses trends in buprenorphine initiation and retention in the United States

Diagnosis and treatment of food allergies using a molecular approach

A call to action proposed for health providers to ensure widest distribution, easy availability of naloxone

Researchers find a way to block anaphylaxis caused by peanut allergies

Researcher contextualizes a study on IgG4 anti-Spike levels after repeated SARS-CoV-2 mRNA vaccination

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

High burden of multi-food allergies among children and adults in the U.S.

New technologies and recent advances in the study of T cells and T-cell epitope discovery in food allergy research

Study sheds new light on the role of IgA in food allergies

Study: Only half of food allergic adult patients have immediate access to epinephrine

Treatment using CRISPR genome editing alleviates swelling attacks in hereditary angioedema patients

Anaphylaxis symptoms in most infants appear to resolve with a single dose of epinephrine

CDC Director signs decision memo allowing Novavax monovalent COVID-19 boosters for adults

Comparative immunogenicity of COVID-19 vaccines in North California

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News